Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.

Abstract

The mechanism of action of interferon (IFN)-beta therapy in multiple sclerosis (MS) is only partially known, and its efficacy changes with disease stage. In different forms of MS, we determined how IFN-beta regulates mononuclear cell production of the important anti-inflammatory Th2 cytokine - IL-10, the Th1 cytokine - IFN-gamma, and the brain-derived… (More)

Topics

  • Presentations referencing similar topics